TKOBF yields 2.64% · PFE yields 6.20%● Live data
📍 TKOBF pulled ahead of the other in Year 1
Combined, TKOBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TKOBF + PFE for your $10,000?
TBS Holdings,Inc. engages in the broadcasting, video and cultural, and real estate businesses primarily in Japan. It is involved in the TV and radio broadcasting, and related activities; and plans, produces, distributes, and sells video, audio, and music software. The company also engages in retailing of general merchandises; manufacturing and selling of cosmetic products; and mail order sales and online businesses. In addition, it is involved in leasing, maintenance, and servicing of real estate properties; operation and management of parking lot; provision of studio and air conditioning management; staffing and accounting work; land rental; heat supply; and leasing of equipment, as well as acts as a non-life insurance agent. The company was formerly known as Tokyo Broadcasting System Holdings, Inc. and changed its name to TBS Holdings,Inc. in October 2020. TBS Holdings,Inc. was incorporated in 1951 and is headquartered in Tokyo, Japan.
Full TKOBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.